From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients

Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized for its global prevalence and potential progression to more severe liver diseases such as non-alcoholic steatohepatitis (NASH). The gut microbiota plays a pivotal role in the pathogenesis of NAFLD, yet the detailed characteristics...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in microbiology Vol. 15; p. 1366744
Main Authors Huang, Furong, Lyu, Bo, Xie, Fanci, Li, Fang, Xing, Yufeng, Han, Zhiyi, Lai, Jianping, Ma, Jinmin, Zou, Yuanqiang, Zeng, Hua, Xu, Zhe, Gao, Pan, Luo, Yonglun, Bolund, Lars, Tong, Guangdong, Fengping, Xu
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 04.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized for its global prevalence and potential progression to more severe liver diseases such as non-alcoholic steatohepatitis (NASH). The gut microbiota plays a pivotal role in the pathogenesis of NAFLD, yet the detailed characteristics and ecological alterations of gut microbial communities during the progression from non-alcoholic fatty liver (NAFL) to NASH remain poorly understood. Methods: In this study, we conducted a comparative analysis of gut microbiota composition in individuals with NAFL and NASH to elucidate differences and characteristics. We utilized 16S rRNA sequencing to compare the intestinal gut microbiota among a healthy control group (65 cases), NAFL group (64 cases), and NASH group (53 cases). Random forest machine learning and database validation methods were employed to analyze the data. Results: Our findings indicate a significant decrease in the diversity of intestinal flora during the progression of NAFLD ( p  < 0.05). At the phylum level, high abundances of Bacteroidetes and Fusobacteria were observed in both NAFL and NASH patients, whereas Firmicutes were less abundant. At the genus level, a significant decrease in Prevotella expression was seen in the NAFL group (AUC 0.738), whereas an increase in the combination of Megamonas and Fusobacterium was noted in the NASH group (AUC 0.769). Furthermore, KEGG pathway analysis highlighted significant disturbances in various types of glucose metabolism pathways in the NASH group compared to the NAFL group, as well as notably compromised flavonoid and flavonol biosynthesis functions. The study uncovers distinct microbiota characteristics and microecological changes within the gut during the transition from NAFL to NASH, providing insights that could facilitate the discovery of novel biomarkers and therapeutic targets for NAFLD.
AbstractList Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized for its global prevalence and potential progression to more severe liver diseases such as non-alcoholic steatohepatitis (NASH). The gut microbiota plays a pivotal role in the pathogenesis of NAFLD, yet the detailed characteristics and ecological alterations of gut microbial communities during the progression from non-alcoholic fatty liver (NAFL) to NASH remain poorly understood. Methods: In this study, we conducted a comparative analysis of gut microbiota composition in individuals with NAFL and NASH to elucidate differences and characteristics. We utilized 16S rRNA sequencing to compare the intestinal gut microbiota among a healthy control group (65 cases), NAFL group (64 cases), and NASH group (53 cases). Random forest machine learning and database validation methods were employed to analyze the data. Results: Our findings indicate a significant decrease in the diversity of intestinal flora during the progression of NAFLD (p < 0.05). At the phylum level, high abundances of Bacteroidetes and Fusobacteria were observed in both NAFL and NASH patients, whereas Firmicutes were less abundant. At the genus level, a significant decrease in Prevotella expression was seen in the NAFL group (AUC 0.738), whereas an increase in the combination of Megamonas and Fusobacterium was noted in the NASH group (AUC 0.769). Furthermore, KEGG pathway analysis highlighted significant disturbances in various types of glucose metabolism pathways in the NASH group compared to the NAFL group, as well as notably compromised flavonoid and flavonol biosynthesis functions. The study uncovers distinct microbiota characteristics and microecological changes within the gut during the transition from NAFL to NASH, providing insights that could facilitate the discovery of novel biomarkers and therapeutic targets for NAFLD.Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized for its global prevalence and potential progression to more severe liver diseases such as non-alcoholic steatohepatitis (NASH). The gut microbiota plays a pivotal role in the pathogenesis of NAFLD, yet the detailed characteristics and ecological alterations of gut microbial communities during the progression from non-alcoholic fatty liver (NAFL) to NASH remain poorly understood. Methods: In this study, we conducted a comparative analysis of gut microbiota composition in individuals with NAFL and NASH to elucidate differences and characteristics. We utilized 16S rRNA sequencing to compare the intestinal gut microbiota among a healthy control group (65 cases), NAFL group (64 cases), and NASH group (53 cases). Random forest machine learning and database validation methods were employed to analyze the data. Results: Our findings indicate a significant decrease in the diversity of intestinal flora during the progression of NAFLD (p < 0.05). At the phylum level, high abundances of Bacteroidetes and Fusobacteria were observed in both NAFL and NASH patients, whereas Firmicutes were less abundant. At the genus level, a significant decrease in Prevotella expression was seen in the NAFL group (AUC 0.738), whereas an increase in the combination of Megamonas and Fusobacterium was noted in the NASH group (AUC 0.769). Furthermore, KEGG pathway analysis highlighted significant disturbances in various types of glucose metabolism pathways in the NASH group compared to the NAFL group, as well as notably compromised flavonoid and flavonol biosynthesis functions. The study uncovers distinct microbiota characteristics and microecological changes within the gut during the transition from NAFL to NASH, providing insights that could facilitate the discovery of novel biomarkers and therapeutic targets for NAFLD.
Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized for its global prevalence and potential progression to more severe liver diseases such as non-alcoholic steatohepatitis (NASH). The gut microbiota plays a pivotal role in the pathogenesis of NAFLD, yet the detailed characteristics and ecological alterations of gut microbial communities during the progression from non-alcoholic fatty liver (NAFL) to NASH remain poorly understood. Methods: In this study, we conducted a comparative analysis of gut microbiota composition in individuals with NAFL and NASH to elucidate differences and characteristics. We utilized 16S rRNA sequencing to compare the intestinal gut microbiota among a healthy control group (65 cases), NAFL group (64 cases), and NASH group (53 cases). Random forest machine learning and database validation methods were employed to analyze the data. Results: Our findings indicate a significant decrease in the diversity of intestinal flora during the progression of NAFLD (p < 0.05). At the phylum level, high abundances of Bacteroidetes and Fusobacteria were observed in both NAFL and NASH patients, whereas Firmicutes were less abundant. At the genus level, a significant decrease in Prevotella expression was seen in the NAFL group (AUC 0.738), whereas an increase in the combination of Megamonas and Fusobacterium was noted in the NASH group (AUC 0.769). Furthermore, KEGG pathway analysis highlighted significant disturbances in various types of glucose metabolism pathways in the NASH group compared to the NAFL group, as well as notably compromised flavonoid and flavonol biosynthesis functions. The study uncovers distinct microbiota characteristics and microecological changes within the gut during the transition from NAFL to NASH, providing insights that could facilitate the discovery of novel biomarkers and therapeutic targets for NAFLD.
Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized for its global prevalence and potential progression to more severe liver diseases such as non-alcoholic steatohepatitis (NASH). The gut microbiota plays a pivotal role in the pathogenesis of NAFLD, yet the detailed characteristics and ecological alterations of gut microbial communities during the progression from non-alcoholic fatty liver (NAFL) to NASH remain poorly understood. Methods: In this study, we conducted a comparative analysis of gut microbiota composition in individuals with NAFL and NASH to elucidate differences and characteristics. We utilized 16S rRNA sequencing to compare the intestinal gut microbiota among a healthy control group (65 cases), NAFL group (64 cases), and NASH group (53 cases). Random forest machine learning and database validation methods were employed to analyze the data. Results: Our findings indicate a significant decrease in the diversity of intestinal flora during the progression of NAFLD ( p  < 0.05). At the phylum level, high abundances of Bacteroidetes and Fusobacteria were observed in both NAFL and NASH patients, whereas Firmicutes were less abundant. At the genus level, a significant decrease in Prevotella expression was seen in the NAFL group (AUC 0.738), whereas an increase in the combination of Megamonas and Fusobacterium was noted in the NASH group (AUC 0.769). Furthermore, KEGG pathway analysis highlighted significant disturbances in various types of glucose metabolism pathways in the NASH group compared to the NAFL group, as well as notably compromised flavonoid and flavonol biosynthesis functions. The study uncovers distinct microbiota characteristics and microecological changes within the gut during the transition from NAFL to NASH, providing insights that could facilitate the discovery of novel biomarkers and therapeutic targets for NAFLD.
Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized for its global prevalence and potential progression to more severe liver diseases such as non-alcoholic steatohepatitis (NASH). The gut microbiota plays a pivotal role in the pathogenesis of NAFLD, yet the detailed characteristics and ecological alterations of gut microbial communities during the progression from non-alcoholic fatty liver (NAFL) to NASH remain poorly understood. Methods: In this study, we conducted a comparative analysis of gut microbiota composition in individuals with NAFL and NASH to elucidate differences and characteristics. We utilized 16S rRNA sequencing to compare the intestinal gut microbiota among a healthy control group (65 cases), NAFL group (64 cases), and NASH group (53 cases). Random forest machine learning and database validation methods were employed to analyze the data. Results: Our findings indicate a significant decrease in the diversity of intestinal flora during the progression of NAFLD (  < 0.05). At the phylum level, high abundances of Bacteroidetes and Fusobacteria were observed in both NAFL and NASH patients, whereas Firmicutes were less abundant. At the genus level, a significant decrease in Prevotella expression was seen in the NAFL group (AUC 0.738), whereas an increase in the combination of Megamonas and Fusobacterium was noted in the NASH group (AUC 0.769). Furthermore, KEGG pathway analysis highlighted significant disturbances in various types of glucose metabolism pathways in the NASH group compared to the NAFL group, as well as notably compromised flavonoid and flavonol biosynthesis functions. The study uncovers distinct microbiota characteristics and microecological changes within the gut during the transition from NAFL to NASH, providing insights that could facilitate the discovery of novel biomarkers and therapeutic targets for NAFLD.
Author Zou, Yuanqiang
Xu, Zhe
Gao, Pan
Xing, Yufeng
Li, Fang
Ma, Jinmin
Luo, Yonglun
Han, Zhiyi
Xie, Fanci
Zeng, Hua
Lyu, Bo
Fengping, Xu
Bolund, Lars
Tong, Guangdong
Huang, Furong
Lai, Jianping
AuthorAffiliation 8 BGI , Shenzhen , China
10 Lars Bolund Institute of Regenerative Medicine, BGI-Qingdao, BGI Research , Qingdao , China
2 Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital , Shenzhen , China
4 College of Life Sciences, University of Chinese Academy of Sciences , Beijing , China
7 People's Hospital of Longhua , Shenzhen , China
6 The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine , Shenzhen , China
11 Department of Infectious Diseases, Shenzhen Traditional Chinese Medicine Hospital , Shenzhen , China
1 Faculty of Chinese Medicine and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology , Macau , China
5 BGI Cell , Shenzhen , China
3 Department of Sanming Project of Medicine in Shenzhen, Shenzhen Traditional Chinese Medicine Hospital , Shenzhen , China
9 Qingdao-Europe Advanced Institute for Life Sciences, BGI Research , Qingdao , China
AuthorAffiliation_xml – name: 1 Faculty of Chinese Medicine and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology , Macau , China
– name: 7 People's Hospital of Longhua , Shenzhen , China
– name: 8 BGI , Shenzhen , China
– name: 5 BGI Cell , Shenzhen , China
– name: 10 Lars Bolund Institute of Regenerative Medicine, BGI-Qingdao, BGI Research , Qingdao , China
– name: 6 The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine , Shenzhen , China
– name: 3 Department of Sanming Project of Medicine in Shenzhen, Shenzhen Traditional Chinese Medicine Hospital , Shenzhen , China
– name: 4 College of Life Sciences, University of Chinese Academy of Sciences , Beijing , China
– name: 9 Qingdao-Europe Advanced Institute for Life Sciences, BGI Research , Qingdao , China
– name: 11 Department of Infectious Diseases, Shenzhen Traditional Chinese Medicine Hospital , Shenzhen , China
– name: 2 Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital , Shenzhen , China
Author_xml – sequence: 1
  givenname: Furong
  surname: Huang
  fullname: Huang, Furong
– sequence: 2
  givenname: Bo
  surname: Lyu
  fullname: Lyu, Bo
– sequence: 3
  givenname: Fanci
  surname: Xie
  fullname: Xie, Fanci
– sequence: 4
  givenname: Fang
  surname: Li
  fullname: Li, Fang
– sequence: 5
  givenname: Yufeng
  surname: Xing
  fullname: Xing, Yufeng
– sequence: 6
  givenname: Zhiyi
  surname: Han
  fullname: Han, Zhiyi
– sequence: 7
  givenname: Jianping
  surname: Lai
  fullname: Lai, Jianping
– sequence: 8
  givenname: Jinmin
  surname: Ma
  fullname: Ma, Jinmin
– sequence: 9
  givenname: Yuanqiang
  surname: Zou
  fullname: Zou, Yuanqiang
– sequence: 10
  givenname: Hua
  surname: Zeng
  fullname: Zeng, Hua
– sequence: 11
  givenname: Zhe
  surname: Xu
  fullname: Xu, Zhe
– sequence: 12
  givenname: Pan
  surname: Gao
  fullname: Gao, Pan
– sequence: 13
  givenname: Yonglun
  surname: Luo
  fullname: Luo, Yonglun
– sequence: 14
  givenname: Lars
  surname: Bolund
  fullname: Bolund, Lars
– sequence: 15
  givenname: Guangdong
  surname: Tong
  fullname: Tong, Guangdong
– sequence: 16
  givenname: Xu
  surname: Fengping
  fullname: Fengping, Xu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38638907$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1vEzEQXaEiWkr_AAfkI5cEf63XywVVFaGVIjgAEjfLa49TV7t2sL2R-u9xmhS1HPDBHo3nvTcev9fNSYgBmuYtwUvGZP_BTd4MS4opXxImRMf5i-aMCMEXDNNfJ0_i0-Yi5ztcF8e07q-aUyZF5cDdWaNWKU5oMxdUIhr9DtJHNIcd-NGHDSq3gKx3DhIEAxlFh3wokIsPekS1gxQHH4uuWfT1crVGOtgafL9GW108hJLfNC-dHjNcHM_z5ufq84-r68X625ebq8v1wnDRl4UFgyWznDnaWe0kNiB7ZskgQMqOSWrbgTlOXYttx5wT1FWIELpj1mkt2Xlzc-C1Ud-pbfKTTvcqaq8eEjFtlE7FmxHUQHBVo0AJb3lrWklFhwfogPTcaaor16cD13YeJrCmviPp8Rnp85vgb9Um7hQh9Ttou-_m_ZEhxd9znZeafDYwjjpAnLNimDPccUz6WvruqdhflccvqgXyUFCHnXMCp4wvdbpxr-1HRbDaG0I9GELtDaGOhqhQ-g_0kf0_oD8A6Lq6
CitedBy_id crossref_primary_10_3389_fnut_2024_1447524
crossref_primary_10_12677_acm_2025_153639
crossref_primary_10_1186_s40001_024_02072_3
crossref_primary_10_3390_jcm14062013
crossref_primary_10_3390_nu16223951
crossref_primary_10_3390_cells14020084
Cites_doi 10.1016/j.cell.2020.05.001
10.7150/jca.24048
10.1038/s41587-020-0548-6
10.1016/j.cgh.2013.02.015
10.1101/gr.244293.118
10.3390/cells9010176
10.3390/nu14061133
10.1038/srep32002
10.1093/jambio/lxac014
10.1159/000519611
10.12688/f1000research.8987.2
10.1016/j.cmet.2019.08.002
10.3389/fimmu.2019.02988
10.1016/j.nut.2020.111081
10.1016/j.jhep.2021.11.029
10.1002/hep.32534
10.3389/fphar.2022.1005312
10.1093/nar/gks1219
10.1002/jcsm.13037
10.1186/s12970-020-00353-w
10.3390/antiox10040559
10.1038/ncomms3163
10.1128/JCM.02239-16
10.3390/nu14153192
10.3390/nu14102010
10.1093/bioinformatics/btq461
10.1093/nar/gkt1209
10.3389/fmicb.2018.01095
10.1002/hep.28356
10.1093/bioinformatics/btu494
10.3390/nu15081841
10.1111/j.1467-985X.2010.00676_9.x
10.1038/s41591-018-0061-3
10.1002/hep.28572
10.1093/bioinformatics/btu393
10.7150/thno.79953
10.1007/s12072-019-09934-7
10.1128/AEM.02914-06
10.1111/1751-2980.12685
10.3390/ijms232415753
10.1016/j.apsb.2019.02.004
10.3390/nu12082393
10.3390/nu13061905
10.1016/S1499-3872(17)60019-5
10.1038/s41587-019-0209-9
10.1007/s11739-023-03339-z
10.1186/s40168-022-01429-2
10.1002/hep.25889
10.1016/j.biopha.2021.111326
10.1002/hep.26093
10.1053/gast.2000.19267
10.1016/j.anaerobe.2019.05.003
10.1101/gr.126573.111
10.1007/s12072-019-09964-1
10.7717/peerj.2584
10.1038/s41598-018-25090-8
ContentType Journal Article
Copyright Copyright © 2024 Huang, Lyu, Xie, Li, Xing, Han, Lai, Ma, Zou, Zeng, Xu, Gao, Luo, Bolund, Tong and Fengping.
Copyright © 2024 Huang, Lyu, Xie, Li, Xing, Han, Lai, Ma, Zou, Zeng, Xu, Gao, Luo, Bolund, Tong and Fengping. 2024 Huang, Lyu, Xie, Li, Xing, Han, Lai, Ma, Zou, Zeng, Xu, Gao, Luo, Bolund, Tong and Fengping
Copyright_xml – notice: Copyright © 2024 Huang, Lyu, Xie, Li, Xing, Han, Lai, Ma, Zou, Zeng, Xu, Gao, Luo, Bolund, Tong and Fengping.
– notice: Copyright © 2024 Huang, Lyu, Xie, Li, Xing, Han, Lai, Ma, Zou, Zeng, Xu, Gao, Luo, Bolund, Tong and Fengping. 2024 Huang, Lyu, Xie, Li, Xing, Han, Lai, Ma, Zou, Zeng, Xu, Gao, Luo, Bolund, Tong and Fengping
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fmicb.2024.1366744
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-302X
ExternalDocumentID oai_doaj_org_article_b10ec02e214545c582670be7e194fa2a
PMC11024258
38638907
10_3389_fmicb_2024_1366744
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
ECGQY
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
PGMZT
RNS
RPM
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c469t-dec083d43f27daf80ce893d1b6e887382d5b3f42f50d73ff62fdec66a73dfaa83
IEDL.DBID DOA
ISSN 1664-302X
IngestDate Wed Aug 27 01:07:14 EDT 2025
Thu Aug 21 18:34:06 EDT 2025
Fri Jul 11 06:57:10 EDT 2025
Thu Apr 03 07:00:07 EDT 2025
Tue Jul 01 02:18:45 EDT 2025
Thu Apr 24 22:52:32 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords NAFLD
gut microbiome
NASH
NAFL
16S rRNA sequencing
Language English
License Copyright © 2024 Huang, Lyu, Xie, Li, Xing, Han, Lai, Ma, Zou, Zeng, Xu, Gao, Luo, Bolund, Tong and Fengping.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c469t-dec083d43f27daf80ce893d1b6e887382d5b3f42f50d73ff62fdec66a73dfaa83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors have contributed equally to this work
Edited by: Mauro Cataldi, University of Naples Federico II, Italy
Zhengrui Li, Shanghai Jiao Tong University, China
Reviewed by: Kendall S. Stocke, University of Louisville, United States
Giovanni Tarantino, University of Naples Federico II, Italy
OpenAccessLink https://doaj.org/article/b10ec02e214545c582670be7e194fa2a
PMID 38638907
PQID 3043074019
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_b10ec02e214545c582670be7e194fa2a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11024258
proquest_miscellaneous_3043074019
pubmed_primary_38638907
crossref_citationtrail_10_3389_fmicb_2024_1366744
crossref_primary_10_3389_fmicb_2024_1366744
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-04-04
PublicationDateYYYYMMDD 2024-04-04
PublicationDate_xml – month: 04
  year: 2024
  text: 2024-04-04
  day: 04
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in microbiology
PublicationTitleAlternate Front Microbiol
PublicationYear 2024
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Huang (ref21) 2023; 13
Galli (ref16) 2022; 14
Demir (ref12) 2022; 76
Kariagina (ref25) 2022; 23
Parks (ref34) 2014; 30
Quast (ref36) 2012; 41
Javdan (ref23) 2020; 181
Bedossa (ref3) 2012; 56
Scavo (ref44) 2022; 14
Cai (ref6) 2020; 14
Davis (ref10) 2019; 10
Pelin (ref35) 2013; 42
Shen (ref46) 2017; 16
Carelli (ref7) 2023; 15
Ward (ref52) 2017
Yokono (ref54) 2018; 8
Chen (ref8) 2016; 5
Labun (ref28) 2019; 29
Douglas (ref13) 2020; 38
Huang (ref22) 2021; 10
Sun (ref47) 2019; 9
Wilkinson (ref53) 2018; 9
Edgar (ref14) 2010; 26
Boursier (ref5) 2016; 63
Sandoval (ref43) 2020; 12
Bolyen (ref4) 2019; 37
Loomba (ref30) 2019; 30
Ren (ref40) 2023; 77
Fan (ref15) 2019; 20
Ginestet (ref17) 2011; 174
Cope (ref9) 2000; 119
Liu (ref29) 2021; 137
Nikkhah (ref33) 2023; 134
Raman (ref38) 2013; 11
Shah (ref45) 2019; 13
Kim (ref26) 2021; 13
Mohr (ref31) 2020; 17
Roeb (ref41) 2022; 38
Tan (ref48) 2022; 13
Zhang (ref56) 2013; 4
Zhu (ref57) 2013; 57
Gu (ref19) 2014; 30
Hoyles (ref20) 2018; 24
Wang (ref50) 2016; 6
Amaretti (ref2) 2007; 73
Zhang (ref55) 2018; 9
Girdhar (ref18) 2023; 11
Jin (ref24) 2022; 14
Del (ref11) 2017; 65
Tarantino (ref49) 2023; 18
Rognes (ref42) 2016; 4
Neubauer (ref32) 2019; 59
Wang (ref51) 2022; 13
Adkins (ref1) 2017; 55
Quesada-Vazquez (ref37) 2020; 9
Ren (ref39) 2021; 83
Kostic (ref27) 2012; 22
References_xml – volume: 181
  start-page: 1661
  year: 2020
  ident: ref23
  article-title: Personalized mapping of drug metabolism by the human gut microbiome
  publication-title: Cell
  doi: 10.1016/j.cell.2020.05.001
– volume: 9
  start-page: 1652
  year: 2018
  ident: ref55
  article-title: Association between fusobacterium nucleatum and colorectal cancer: progress and future directions
  publication-title: J. Cancer
  doi: 10.7150/jca.24048
– volume: 38
  start-page: 685
  year: 2020
  ident: ref13
  article-title: Picrust2 for prediction of metagenome functions
  publication-title: Nat. Biotechnol.
  doi: 10.1038/s41587-020-0548-6
– volume: 11
  start-page: 868
  year: 2013
  ident: ref38
  article-title: Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease
  publication-title: Clin. Gastroenterol. Hepatol.
  doi: 10.1016/j.cgh.2013.02.015
– volume: 29
  start-page: 843
  year: 2019
  ident: ref28
  article-title: Accurate analysis of genuine crispr editing events with amplican
  publication-title: Genome Res.
  doi: 10.1101/gr.244293.118
– volume: 9
  start-page: 176
  year: 2020
  ident: ref37
  article-title: Diet, gut microbiota and non-alcoholic fatty liver disease: three parts of the same axis
  publication-title: Cells
  doi: 10.3390/cells9010176
– start-page: 133462
  volume-title: Bugbase predicts organism level microbiome phenotypes BioRxiv
  year: 2017
  ident: ref52
– volume: 14
  start-page: 1133
  year: 2022
  ident: ref44
  article-title: Exosomal fzd-7 expression is modulated by different lifestyle interventions in patients with nafld
  publication-title: Nutrients
  doi: 10.3390/nu14061133
– volume: 6
  start-page: 32002
  year: 2016
  ident: ref50
  article-title: Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease
  publication-title: Sci. Rep.
  doi: 10.1038/srep32002
– volume: 134
  start-page: lxac014
  year: 2023
  ident: ref33
  article-title: The critical role of gut microbiota dysbiosis in skeletal muscle wasting: a systematic review
  publication-title: J. Appl. Microbiol.
  doi: 10.1093/jambio/lxac014
– volume: 38
  start-page: 126
  year: 2022
  ident: ref41
  article-title: Diagnostic and therapy of nonalcoholic fatty liver disease: a narrative review
  publication-title: Visc. Med.
  doi: 10.1159/000519611
– volume: 5
  start-page: 1438
  year: 2016
  ident: ref8
  article-title: From reads to genes to pathways: differential expression analysis of rna-seq experiments using rsubread and the edger quasi-likelihood pipeline
  publication-title: F1000Res
  doi: 10.12688/f1000research.8987.2
– volume: 30
  start-page: 607
  year: 2019
  ident: ref30
  article-title: Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2019.08.002
– volume: 10
  start-page: 2988
  year: 2019
  ident: ref10
  article-title: Optimization of in vivo imaging provides a first look at mouse model of non-alcoholic fatty liver disease (nafld) using intravital microscopy
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.02988
– volume: 83
  start-page: 111081
  year: 2021
  ident: ref39
  article-title: Alterations of intestinal microbiota in liver cirrhosis with muscle wasting
  publication-title: Nutrition
  doi: 10.1016/j.nut.2020.111081
– volume: 76
  start-page: 788
  year: 2022
  ident: ref12
  article-title: The fecal mycobiome in non-alcoholic fatty liver disease
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2021.11.029
– volume: 77
  start-page: 230
  year: 2023
  ident: ref40
  article-title: Relationship between nafld and coronary artery disease: a mendelian randomization study
  publication-title: Hepatology
  doi: 10.1002/hep.32534
– volume: 13
  start-page: 1005312
  year: 2022
  ident: ref48
  article-title: Natural flavonoids: potential therapeutic strategies for non-alcoholic fatty liver disease
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2022.1005312
– volume: 41
  start-page: D590
  year: 2012
  ident: ref36
  article-title: The silva ribosomal rna gene database project: improved data processing and web-based tools
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gks1219
– volume: 13
  start-page: 2340
  year: 2022
  ident: ref51
  article-title: Population-based metagenomics analysis reveals altered gut microbiome in sarcopenia: data from the xiangya sarcopenia study
  publication-title: J. Cachexia. Sarcopenia Muscle
  doi: 10.1002/jcsm.13037
– volume: 17
  start-page: 24
  year: 2020
  ident: ref31
  article-title: The athletic gut microbiota
  publication-title: J. Int. Soc. Sport Nutr.
  doi: 10.1186/s12970-020-00353-w
– volume: 10
  start-page: 559
  year: 2021
  ident: ref22
  article-title: Cisd2 protects the liver from oxidative stress and ameliorates western diet-induced nonalcoholic fatty liver disease
  publication-title: Antioxidants.
  doi: 10.3390/antiox10040559
– volume: 4
  start-page: 2163
  year: 2013
  ident: ref56
  article-title: Structural modulation of gut microbiota in life-long calorie-restricted mice
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms3163
– volume: 55
  start-page: 1778
  year: 2017
  ident: ref1
  article-title: Species identification and strain typing of staphylococcus agnetis and staphylococcus hyicus isolates from bovine milk by use of a novel multiplex pcr assay and pulsed-field gel electrophoresis
  publication-title: J. Clin. Microbiol.
  doi: 10.1128/JCM.02239-16
– volume: 14
  start-page: 3192
  year: 2022
  ident: ref16
  article-title: Sex-gender differences in adult coeliac disease at diagnosis and gluten-free-diet follow-up
  publication-title: Nutrients
  doi: 10.3390/nu14153192
– volume: 14
  start-page: 2010
  year: 2022
  ident: ref24
  article-title: A novel herbal extract blend product prevents particulate matters-induced inflammation by improving gut microbiota and maintaining the integrity of the intestinal barrier
  publication-title: Nutrients
  doi: 10.3390/nu14102010
– volume: 26
  start-page: 2460
  year: 2010
  ident: ref14
  article-title: Search and clustering orders of magnitude faster than blast
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btq461
– volume: 42
  start-page: D643
  year: 2013
  ident: ref35
  article-title: The silva and "all-species living tree project (ltp)" taxonomic frameworks
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkt1209
– volume: 9
  start-page: 1095
  year: 2018
  ident: ref53
  article-title: Cowpi: a rumen microbiome focussed version of the picrust functional inference software
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2018.01095
– volume: 63
  start-page: 764
  year: 2016
  ident: ref5
  article-title: The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
  publication-title: Hepatology
  doi: 10.1002/hep.28356
– volume: 30
  start-page: 3123
  year: 2014
  ident: ref34
  article-title: Stamp: statistical analysis of taxonomic and functional profiles
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btu494
– volume: 15
  start-page: 1841
  year: 2023
  ident: ref7
  article-title: Modulation of gut microbiota through low-calorie and two-phase diets in obese individuals
  publication-title: Nutrients
  doi: 10.3390/nu15081841
– volume: 174
  start-page: 245
  year: 2011
  ident: ref17
  article-title: Ggplot2: elegant graphics for data analysis
  publication-title: J. R. Stat. Soc.
  doi: 10.1111/j.1467-985X.2010.00676_9.x
– volume: 24
  start-page: 1070
  year: 2018
  ident: ref20
  article-title: Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
  publication-title: Nat. Med.
  doi: 10.1038/s41591-018-0061-3
– volume: 65
  start-page: 451
  year: 2017
  ident: ref11
  article-title: Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach
  publication-title: Hepatology
  doi: 10.1002/hep.28572
– volume: 30
  start-page: 2811
  year: 2014
  ident: ref19
  article-title: Circlize implements and enhances circular visualization in r
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btu393
– volume: 13
  start-page: 639
  year: 2023
  ident: ref21
  article-title: Three-dimensional mapping of hepatic lymphatic vessels and transcriptome profiling of lymphatic endothelial cells in healthy and diseased livers
  publication-title: Theranostics
  doi: 10.7150/thno.79953
– volume: 13
  start-page: 110
  year: 2019
  ident: ref45
  article-title: Serum ferritin as a biomarker for nafld: ready for prime time?
  publication-title: Hepatol. Int.
  doi: 10.1007/s12072-019-09934-7
– volume: 73
  start-page: 3637
  year: 2007
  ident: ref2
  article-title: Kinetics and metabolism of bifidobacterium adolescentis mb 239 growing on glucose, galactose, lactose, and galactooligosaccharides
  publication-title: Appl. Environ. Microbiol.
  doi: 10.1128/AEM.02914-06
– volume: 20
  start-page: 163
  year: 2019
  ident: ref15
  article-title: Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)
  publication-title: J. Dig. Dis.
  doi: 10.1111/1751-2980.12685
– volume: 23
  start-page: 15753
  year: 2022
  ident: ref25
  article-title: Anti-inflammatory mechanisms of dietary flavones: tapping into nature to control chronic inflammation in obesity and cancer
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms232415753
– volume: 9
  start-page: 702
  year: 2019
  ident: ref47
  article-title: Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters
  publication-title: Acta Pharm. Sin. B
  doi: 10.1016/j.apsb.2019.02.004
– volume: 12
  start-page: 2393
  year: 2020
  ident: ref43
  article-title: Metabolic impact of flavonoids consumption in obesity: from central to peripheral
  publication-title: Nutrients
  doi: 10.3390/nu12082393
– volume: 13
  start-page: 1905
  year: 2021
  ident: ref26
  article-title: Microbiota and metabolite modifications after dietary exclusion of dairy products and reduced consumption of fermented food in young and older men
  publication-title: Nutrients
  doi: 10.3390/nu13061905
– volume: 16
  start-page: 375
  year: 2017
  ident: ref46
  article-title: Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease
  publication-title: Hepatob. Pancreatic. Dis. Int.
  doi: 10.1016/S1499-3872(17)60019-5
– volume: 37
  start-page: 852
  year: 2019
  ident: ref4
  article-title: Reproducible, interactive, scalable and extensible microbiome data science using qiime 2
  publication-title: Nat. Biotechnol.
  doi: 10.1038/s41587-019-0209-9
– volume: 18
  start-page: 1887
  year: 2023
  ident: ref49
  article-title: Sarcopenia, a condition shared by various diseases: can we alleviate or delay the progression?
  publication-title: Intern. Emerg. Med.
  doi: 10.1007/s11739-023-03339-z
– volume: 11
  start-page: 9
  year: 2023
  ident: ref18
  article-title: Dynamics of the gut microbiome, Iga response, and plasma metabolome in the development of pediatric celiac disease
  publication-title: Microbiome.
  doi: 10.1186/s40168-022-01429-2
– volume: 56
  start-page: 1751
  year: 2012
  ident: ref3
  article-title: Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
  publication-title: Hepatology
  doi: 10.1002/hep.25889
– volume: 137
  start-page: 111326
  year: 2021
  ident: ref29
  article-title: New insight and potential therapy for nafld: cyp2e1 and flavonoids
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2021.111326
– volume: 57
  start-page: 601
  year: 2013
  ident: ref57
  article-title: Characterization of gut microbiomes in nonalcoholic steatohepatitis (Nash) patients: a connection between endogenous alcohol and Nash
  publication-title: Hepatology
  doi: 10.1002/hep.26093
– volume: 119
  start-page: 1340
  year: 2000
  ident: ref9
  article-title: Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis
  publication-title: Gastroenterology
  doi: 10.1053/gast.2000.19267
– volume: 59
  start-page: 38
  year: 2019
  ident: ref32
  article-title: Effects of clay mineral supplementation on particle-associated and epimural microbiota, and gene expression in the rumen of cows fed high-concentrate diet
  publication-title: Anaerobe
  doi: 10.1016/j.anaerobe.2019.05.003
– volume: 22
  start-page: 292
  year: 2012
  ident: ref27
  article-title: Genomic analysis identifies association of fusobacterium with colorectal carcinoma
  publication-title: Genome Res.
  doi: 10.1101/gr.126573.111
– volume: 14
  start-page: 115
  year: 2020
  ident: ref6
  article-title: Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis
  publication-title: Hepatol. Int.
  doi: 10.1007/s12072-019-09964-1
– volume: 4
  start-page: e2584
  year: 2016
  ident: ref42
  article-title: Vsearch: a versatile open source tool for metagenomics
  publication-title: Peerj.
  doi: 10.7717/peerj.2584
– volume: 8
  start-page: 6800
  year: 2018
  ident: ref54
  article-title: Comparative analyses of whole-genome protein sequences from multiple organisms
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-25090-8
SSID ssj0000402000
Score 2.4150639
Snippet Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized for its global prevalence and potential progression to more severe liver diseases such as...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1366744
SubjectTerms 16S rRNA sequencing
gut microbiome
Microbiology
NAFL
NAFLD
NASH
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fi9QwEB7OE8EXOX9XT4ngm1TSJG1a4ThOcVnEuxdduLeQNMndwl6ru13x_ntn2u7iyumTbyVN0nQmk_mmTb4BeC0qzoOLGJvY0qeq4DatcA1MbVkLT6cfc0ffIU_PiulMfTrPz_dgk-5oFODqxtCO8knNlou3P79fH6PBH1HEif4WNTCvHYZ6QtGmrUIrdQtuo2fSZKinI9zvV2YKljgfzs78pemOf-pp_G_Cnn9uofzNJ00O4N4IJtnJoP37sBeaB3BnSC95_RDMZNlesYt1x7qWLWgDxju2bn6EOR1BZ4j82CY9Ci4WrI2MuCPQ5KnPq_nA0NRZLGVnJ5PPzDYeL75M2cjFunoEs8nHrx-m6ZhQIa0xCu5SH2pEXF7JKLS3seR1QLjiM1cEXGtkKXzuZFQi5txrGWMhIjYpCqulj9aW8jHsN20TngKLzmZO1TrIyitthVNFQDiAHaLHt1YkkG3EaOqRbZySXiwMRh0ketOL3pDozSj6BN5s23wbuDb-Wfs9aWdbk3iy-4J2eWFGszMu4_jOIhAfu8rrHEenuQs6ZJWKVtgEXm10a9Cu6GeJbUK7XhlJZGiUrrBK4Mmg6-2jZEk4j-sEyp1ZsDOW3TvN_LLn7ka0RUFe-ex_jP453CWJ9BuJ1CHsd8t1eIEYqXMv-4n_C9ICEGo
  priority: 102
  providerName: Scholars Portal
Title From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients
URI https://www.ncbi.nlm.nih.gov/pubmed/38638907
https://www.proquest.com/docview/3043074019
https://pubmed.ncbi.nlm.nih.gov/PMC11024258
https://doaj.org/article/b10ec02e214545c582670be7e194fa2a
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PS-QwFA4iLHiRdXXd6q5E8LYU0yRtUm_usuMg6sUV5haSJtkd0Fa0I_jf73ttZ5hZRC9eQunP8PKa933ty_cIOeIlY8FF4CZW-1QWzKYlzIGp1RX3uPoxd_gd8vKqGN_I80k-WSr1hTlhvTxwb7hjl7FQMR5QUVvmVQ5wWDEXVAD2HS3voBHEvCUy1c3BSIsY61fJAAsrYZimlQM-yCVmdhVKypVI1An2v4Qy_0-WXIo-o49kc4CN9LTv7hZZC_Un8qEvJPm8Tczoobmjf2YtbRt6i6kWJ3RWP4UpLjangPHovBAKTAu0iRRVIuDlxnveTXstptbCXnp1OrqgtvawcT2mg-rq4w65Gf36_XOcDqUT0gr4bpt6sJkWXorIlbdRsyoAMPGZKwLMKkJznzsRJY8580rEWPAIlxSFVcJHa7X4TNbrpg5fCI3OZk5WKojSS2W5k0WAwA83hNhuLU9INjejqQZdcSxvcWuAX6DpTWd6g6Y3g-kT8n1xzX2vqvHq2T9wdBZnoiJ2twP8xAx-Yt7yk4QczsfWwBuEv0VsHZrZoxEoe4aFCcuE7PZjvXiU0IjomEqIXvGClb6sHqmnfzuVbsBVSOf03nv0fp9soEW6lCH5lay3D7PwDdBQ6w46x4f2bJJBeyn1PxHwCYA
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=From+gut+to+liver%3A+unveiling+the+differences+of+intestinal+microbiota+in+NAFL+and+NASH+patients&rft.jtitle=Frontiers+in+microbiology&rft.au=Furong+Huang&rft.au=Furong+Huang&rft.au=Furong+Huang&rft.au=Bo+Lyu&rft.date=2024-04-04&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-302X&rft.volume=15&rft_id=info:doi/10.3389%2Ffmicb.2024.1366744&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_b10ec02e214545c582670be7e194fa2a
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-302X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-302X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-302X&client=summon